Enanta SVP & General Counsel Gardiner to retire by March 31, 2024; consulting role

ENANTA PHARMACEUTICALS INC

Nathaniel S. Gardiner, age 70, plans to retire as SVP and General Counsel on or before March 31, 2024.
Company expects to enter a consulting agreement with Gardiner for up to one year post-retirement.
No successor has been named; search process not disclosed in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Nathaniel S. Gardiner

Senior Vice President and General Counsel

ENTA · ENANTA PHARMACEUTICALS INC

Effective: 2024-03-31
Filed: December 26, 2023, 6:59 PM ET

On December 19, 2023, Nathaniel S. Gardiner, age 70, Senior Vice President and General Counsel of Enanta Pharmaceuticals, Inc., announced his intention to retire on or before March 31, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nathaniel S. Gardiner departed as Senior Vice President and General Counsel at ENANTA PHARMACEUTICALS INC.

Action: retire
Role: Senior Vice President and General Counsel

Exact text from the filing

On December 19, 2023, Nathaniel S. Gardiner, age 70, Senior Vice President and General Counsel of Enanta Pharmaceuticals, Inc., announced his intention to retire on or before March 31, 2024.

View on SEC.gov

ENANTA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001193125-23-303014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.